Cargando…

A global investment framework for the elimination of hepatitis B

BACKGROUND & AIMS: More than 292 million people are living with hepatitis B worldwide and are at risk of death from cirrhosis and liver cancer. The World Health Organization (WHO) has set global targets for the elimination of viral hepatitis as a public health threat by 2030. However, current le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howell, Jessica, Pedrana, Alisa, Schroeder, Sophia E., Scott, Nick, Aufegger, Lisa, Atun, Rifat, Baptista-Leite, Ricardo, Hirnschall, Gottfried, ‘t Hoen, Ellen, Hutchinson, Sharon J., Lazarus, Jeffrey V., Olufunmilayo, Lesi, Peck, Raquel, Sharma, Manik, Sohn, Annette H., Thompson, Alexander, Thursz, Mark, Wilson, David, Hellard, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505744/ https://www.ncbi.nlm.nih.gov/pubmed/32971137 http://dx.doi.org/10.1016/j.jhep.2020.09.013

Ejemplares similares

Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
por: Schröeder, Sophia E., et al.
Publicado: (2019)

Pathways to ensure universal and affordable access to hepatitis C treatment
por: Douglass, Caitlin H., et al.
Publicado: (2018)

Affordable treatment and political commitment are crucial to eliminate hepatitis C globally
por: Hellard, Margaret, et al.
Publicado: (2021)

Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
por: Popping, Stephanie, et al.
Publicado: (2018)

Effect of Investment in Malaria Control on Child Mortality in Sub-Saharan Africa in 2002–2008
por: Akachi, Yoko, et al.
Publicado: (2011)

Global health initiative investments and health systems strengthening: a content analysis of global fund investments
por: Warren, Ashley E, et al.
Publicado: (2013)

How far are we from viral hepatitis elimination service coverage targets?
por: Hutin, Yvan J‐F, et al.
Publicado: (2018)

New progress towards elimination of mother-to-child transmission of hepatitis B virus in China
por: Zheng, Hui, et al.
Publicado: (2022)

Australia needs to increase testing to achieve hepatitis C elimination
por: Scott, Nick, et al.
Publicado: (2020)

Investing in sepsis research: systematic analysis of UK public and philanthropic funding 1997–2010
por: Fitchett, Joseph R, et al.
Publicado: (2014)

Pathway to global elimination of hepatitis B: HBV cure is just the first step
por: Howell, Jessica, et al.
Publicado: (2023)

Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Worldwide, 2016–2021
por: Khetsuriani, Nino, et al.
Publicado: (2022)

Hepatitis C risk perceptions and attitudes towards reinfection among HIV‐diagnosed gay and bisexual men in Melbourne, Australia
por: Schroeder, Sophia E, et al.
Publicado: (2019)

Investments in sexually transmitted infection research, 1997–2013: a systematic analysis of funding awarded to UK institutions
por: Head, Michael G, et al.
Publicado: (2015)

Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries
por: Resch, Stephen, et al.
Publicado: (2011)

Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019
por: Lee Wilkinson, Anna, et al.
Publicado: (2021)

Health systems strengthening: a common classification and framework for investment analysis
por: Shakarishvili, George, et al.
Publicado: (2011)

Negative health system effects of Global Fund's investments in AIDS, tuberculosis and malaria from 2002 to 2009: systematic review
por: Car, Josip, et al.
Publicado: (2012)

Funding Infectious Disease Research: A Systematic Analysis of UK Research Investments by Funders 1997–2010
por: Fitchett, Joseph R., et al.
Publicado: (2014)

Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 – CORRIGENDUM
por: Lee Wilkinson, Anna, et al.
Publicado: (2022)

Strengthening vaccine confidence during the COVID-19 pandemic: A new opportunity for global hepatitis B virus elimination
por: Lazarus, Jeffrey V., et al.
Publicado: (2020)

Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
por: Ford, Nathan, et al.
Publicado: (2013)

WHO URGES COUNTRIES TO INVEST IN ELIMINATING HEPATITIS
Publicado: (2019)

Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997–2010
por: Head, Michael G, et al.
Publicado: (2013)

Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997–2013
por: Head, Michael G., et al.
Publicado: (2015)

Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients
por: Draper, Bridget, et al.
Publicado: (2022)

The Global Fund's resource allocation decisions for HIV programmes: addressing those in need
por: Avdeeva, Olga, et al.
Publicado: (2011)

Letter to the Editor: Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective
por: Harney, Brendan, et al.
Publicado: (2020)

Investments in respiratory infectious disease research 1997–2010: a systematic analysis of UK funding
por: Head, Michael G, et al.
Publicado: (2014)

The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia
por: Gunn, Jack, et al.
Publicado: (2023)

Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study
por: Draper, Bridget Louise, et al.
Publicado: (2020)

Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997–2013
por: Head, Michael G., et al.
Publicado: (2015)

Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
por: Scott, Nick, et al.
Publicado: (2018)

Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions
por: Wallace, Jack, et al.
Publicado: (2022)

Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness
por: Hontelez, Jan A.C., et al.
Publicado: (2016)

Trial and error: evaluating and refining a community model of HIV testing in Australia
por: Ryan, Kathleen E., et al.
Publicado: (2017)

Recent setbacks in measles elimination: the importance of investing in innovations for immunizations
por: Goodson, James L.
Publicado: (2020)

Investments in cancer research awarded to UK institutions and the global burden of cancer 2000–2013: a systematic analysis
por: Maruthappu, Mahiben, et al.
Publicado: (2017)

The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments
por: Head, Michael G, et al.
Publicado: (2020)

Prevalence of sexualized drug use and risk of HIV among sexually active MSM in East and South Asian countries: systematic review and meta‐analysis
por: Nevendorff, Laura, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v7u3vnosgkm8ge4bsf61cqhg6f